Patents
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
02/2010
02/24/2010EP2155753A1 Substituted imidazopyridazines as pi3k lipid kinase inhibitors
02/24/2010EP2155747A1 Imidazol (1,2-a)pyridines and related compounds with activity at cannabinoid cb2 receptors
02/24/2010EP2155676A2 Compounds with antiparasitic activity, applications thereof to the treatment of infectious diseases caused by apicomplexans
02/24/2010EP2155672A1 Prolinamide derivatives as nk3 antagonists
02/24/2010EP2155202A2 3,6-disubstituted-imidazo[1,2-b]pyridazines and 3,5-disubstituted pyrazolo[1,5-a]pyrimidines as phosphatidylinositol-3-kinase inhibitors
02/24/2010EP2059520B1 1,4,5,6,7,8-hexahydro-i,2,5-triaza-azulene derivatives as orexin receptor antagonists
02/24/2010EP1713808B1 Two-phase method for the synthesis of selected pyrazolopyrimidines
02/24/2010EP1706411B1 Method for preparing phthalocyanines
02/24/2010EP1636225B1 Pyridino 1,2-a pyrimidin-4-one compounds as anticancer agents
02/24/2010EP1465631B1 Pyrimidine a2b selective antagonist compounds, their synthesis and use
02/24/2010EP1461316B1 Synthesis of 2-cyanoziridine-1-carboxamide
02/24/2010CN101657455A Compounds for the treatment of hepatitis C
02/24/2010CN101654455A Pyrrole [1, 2-a] imidazolium compound and preparation method and anti-tumor application thereof
02/23/2010USRE41150 Poly(adenosine 5'-diphospho-ribose) polymerase (PARP) inhibitors; compounds based on thieno(4,3,2-ef)(2)benzazepin-6-one
02/23/2010US7667041 Cinnamide compound
02/23/2010US7667037 Processes for preparation of ziprasidone
02/23/2010US7667036 Pyrazolo[1,5-a]pyrimidine derivatives
02/23/2010US7666897 Analogs of indole-3-carbinol metabolites as chemotherapeutic and chemopreventive agents
02/23/2010US7666647 Unphosphorylated glycogen synthase kinase-3-g-beta (GSK) from baculovirus overexpression system; competitive binding; diabetes, Alzheimer's disease
02/18/2010WO2010019899A1 cMET INHIBITORS
02/18/2010WO2010018868A1 Pest control agent containing triazolopyrimidine derivative or salt thereof
02/18/2010WO2010018853A1 Pyridyl-triazolopyrimidine derivative or salt thereof, and harmful organism control agent comprising the same
02/18/2010WO2010018832A1 Catalyst for degrading lignin, catalyst for degrading aromatic hydrocarbon, and porphyrin
02/18/2010WO2010018481A1 2-amino pyrimidine compounds as potent hsp-90 inhibitors
02/18/2010WO2010018327A1 2-alkyl-6-cycloamino-3-(pyridin-4-yl)imidazo[1,2-ib]-pyridazine derivatives, preparation thereof, and therapeutic application thereof
02/18/2010WO2010017870A1 Bicyclic triazole derivatives for treating tumors
02/18/2010WO2009158374A3 Inhibitors of akt activity
02/18/2010US20100041881 Optically active ammonium salt compound, production intermediate thereof, and production method thereof
02/18/2010US20100041681 2-amino pyrimidine compounds as potent hsp-90 inhibitors
02/18/2010US20100041676 Kinase inhibitors
02/18/2010US20100041662 Heterocyclic compounds as antiinflammatory agents
02/18/2010US20100041639 Cyclic malonamides as inhibitors of a beta protein production
02/18/2010US20100041545 Catalysts and methods for catalytic oxidation
02/18/2010CA2734077A1 2-alkyl-6-cycloamino-3-(pyridin-4-yl)imidazo[1,2-ib]-pyridazine derivatives, preparation thereof, and therapeutic application thereof
02/18/2010CA2733941A1 Bicyclic triazole derivatives for the treatment of tumours
02/18/2010CA2733528A1 Catalyst for the decomposition of lignin, method for the preparation of alcohols and organic acids, method for the preparation of lignin-decomposition products, catalyst for the decomposition of aromatic hydrocarbons, method for releasing hydrogen ions, as well as porphyrin
02/18/2010CA2733247A1 Heterocyclic amide derivatives as ep4 receptor antagonists
02/18/2010CA2732922A1 2-amino pyrimidine compounds as potent hsp-90 inhibitors
02/18/2010CA2731108A1 Cmet inhibitors
02/17/2010EP2154140A1 Metallocenyl phthalocyanine compounds and use thereof in optical recording media
02/17/2010EP2154139A1 Bicyclic heterocyclic compound
02/17/2010EP2154135A1 Therapeutic agent for cerebral infarction
02/17/2010EP2152714A1 Spiroindolinone derivatives
02/17/2010EP2152713A1 Pyrazolopyrrolidines as inhibitors of gamma secretase
02/17/2010EP2152712A1 Amino-heterocyclic compounds
02/17/2010EP2152707A1 [6,5]-bicyclic gpr119 g protein-coupled receptor agonists
02/17/2010EP2152706A1 Pyrazolo-pyridinone and pyrazolo-pyrazinone compounds as p38 modulators, process for their preparation, and their pharmaceutical use
02/17/2010EP2152695A2 Gamma secretase modulators
02/17/2010EP2152664A1 Dipeptide analogs as coagulation factor inhibitors
02/17/2010EP2152271A1 Piperidine/piperazine derivatives
02/17/2010EP2038285B1 Adenosine a2a receptor antagonists
02/17/2010EP1828200B1 Bi- and tricyclic substituted phenyl methanones as glycine transporter i (glyt-1) inhibitors for the treatment of alzheimer's disease.
02/17/2010EP1347950B1 Derivatives of 4-hydroxybutanoic acid and of its higher homologue as ligands of gamma-hydroxybutyrate (ghb) receptors, pharmaceutical compositions containing same and pharmaceutical uses
02/17/2010CN101652368A processes for making zilpaterol and salts thereof
02/17/2010CN101652367A Pyrimido [4, 5-D] azepine derivatives as 5-HT2C agonists
02/17/2010CN101652366A New classical antifolates
02/17/2010CN101648956A Method for extracting chlorophyll from silkworm excrement by using supercritical fluid
02/17/2010CN101648955A Method for extracting chlorophyll from spirulina by using supercritical fluid
02/17/2010CN101648954A Organic metallic complexes containing phthalocyanine compound and use thereof
02/17/2010CN101648953A Imidazo (1,2-b) pyrrolo (1,2-f) pyridazine derivative as well as preparation method and application thereof
02/17/2010CN101648944A 病毒聚合酶抑制剂 Viral polymerase inhibitors
02/17/2010CN101647802A 5,7-diaminopyrazolo [4,3-d] pyrimidines with pde-5 inhibiting activity and composition thereof
02/16/2010US7663301 for use as robust red organic phosphors
02/16/2010US7662974 Process for producing fused imidazole compound, reformatsky reagent in stable form, and process for producing the same
02/16/2010US7662960 Structures have utility over a wide range of fields, including use as diagnostic and therapeutic agents; kinase inhibitors
02/16/2010US7662846 Selective spirocyclic glucocorticoid receptor modulators
02/16/2010US7662826 Pyrazolo [1,5-a] pyrimidine derivative and nad (p) h oxidase inhibitor containing the same
02/16/2010US7662817 Psychological disorders; central nervous system disorders; antidepressants; anxiolytic agents; stress reliever; irritable bowel syndrome
02/16/2010US7662812 disorders related to smooth muscle contraction, endocrine diseases or disorders, diseases or disorders related to neuro-degeneration, diseases or disorders related to inflammation, pain, and withdrawal symptoms caused by the termination of abuse of chemical substances
02/16/2010US7662808 Diazabicyclic aryl derivatives as cholinergic receptor modulators
02/16/2010US7662807 Sulphonated meso-tetraphenyl chlorins
02/16/2010US7662362 Nanoparticulate probe for in vivo monitoring of tissue oxygenation
02/16/2010CA2528008C 2-substituted phenyl-5,7-dialkyl-3,7-dihydropyrrolo[2,3-d]pyrimidin-4-one derivatives, the preparation and the pharmaceutical use thereof
02/16/2010CA2410399C 5-aminoalkylpyrazolo[4,3-d]pyrimidines
02/16/2010CA2406095C Synthetic process for the manufacture of an ecteinaschidin compound
02/16/2010CA2385938C Cyclic amine compounds as ccr5 antagonists
02/16/2010CA2309154C Substituted porphyrins
02/16/2010CA2225822C Nitroimidazole antibacterial compounds and methods of use thereof
02/11/2010WO2010017105A1 Urotensin ii receptor antagonists
02/11/2010WO2010017093A2 Dopamine receptor ligands with enhanced duration of action
02/11/2010WO2010017055A2 Dihydropyridophthalazinone inhibitors of poly(adp-ribose)polymerase (parp)
02/11/2010WO2010016005A1 6 substituted 2-heterocyclylamino pyrazine compounds as chk-1 inhibitors
02/11/2010WO2010015972A1 Diazepine and diazocane compounds as mc4 agonists
02/11/2010WO2010015803A1 Diazaindole derivatives and their use in the inhibition of c-jun n-terminal kinase
02/11/2010WO2010015545A1 Process for the preparation of a macrocycle
02/11/2010WO2010015520A1 Substituted naphthyridines and use thereof as medicines
02/11/2010US20100036123 Process for the preparation of 2,4-dichloro-7h-pyrrolo[2,3h]quinazoline
02/11/2010US20100036121 Process for preparing temozolomide
02/11/2010US20100036119 Fluorinating reagents and their preparation
02/11/2010US20100036108 Universal Base
02/11/2010US20100035916 Azabicycloalkane derivatives, preparation thereof and use thereof in therapy
02/11/2010US20100035903 administering 3-{4-Methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile or salts, for the treatment of dermatitis, Crohn's disease, inflammatory bowel disease, transplant rejection, lupus, multiple sclerosis, arthritis, psoriasis, diabetes and autoimmune diseases
02/11/2010US20100035900 6-Arylmethyl-substituted pyrazolopyrimidines
02/11/2010US20100035898 Organic compounds
02/11/2010US20100035891 Pharmaceutically Active Compounds
02/11/2010US20100035870 Pyrimidin-4-yl-3, 4-Dihydro-2H-Pyrrolo[1,2A] Pyrazin-1-one Compounds
02/11/2010CA2732797A1 Dihydropyridophthalazinone inhibitors of poly(adp-ribose)polymerase (parp)
02/11/2010CA2732762A1 Urotensin ii receptor antagonists
02/11/2010CA2732165A1 Therapeutic agents 414
02/11/2010CA2732091A1 Process for the preparation of a macrocycle